“I’m not opposed to the concept of equity financing, I believe that preserving equity is fundamental to preserving a Founder’s vision,” said Ryan Saadi, Founder and CEO of Tevogen Bio. “From a ...
Speaking this week at BIO CEO, the heads of Septerna, Upstream Bio and Actuate Therapeutics shared lessons from going public ...
Life sciences trade association BioNJ has announced the election of its 2025 Officers and Board Members in concert with BioNJ ...
Hosted on MSN1d
Dr. Kristine Torjesen appointed president and CEO of BioLogos, founder Francis Collins 'absolutely delighted'Dr. Kristine Torjesen has been announced as the third president and new chief executive officer of BioLogos, the faith and ...
Ochsner Health has named David Callecod as the Chief Executive Officer (CEO) of the Ochsner LSU Health System of North ...
Henry Gosebruch, Neumora’s CEO since 2023, will depart. Elsewhere, Biogen dropped two antisense drugs in a pipeline cull and Voyager hit a setback for its ALS gene therapy.
PRINCETON - Sonnet BioTherapeutics Holdings, Inc. (NASDAQ:SONN), a clinical-stage biotechnology company specializing in immunotherapy treatments with a current market capitalization of $4.69 million, ...
Adrian Lam appointed President and CEO of CorVista HealthDon Crawford to retire following a distinguished 42-year career in MedTechTim Attebery ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback